JOHN P GANDOLFO
CIK 1200155 · Chief Financial Officer · last filed 2025-12-15
JOHN P GANDOLFO is a Chief Financial Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for OGEN, was dated Dec 15, 2025. Across all open-market trades the lifetime net is +$95.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $536.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$536.5K
4
32
$95.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | Director | — | $0.50 | — | $0 | 3 | 2025-12-15 |
| ECOR | Director | 88,098 | $6.09 | $536.5K | $29.4K | 10 | 2025-09-04 |
| HYPERION DEFI, INC. (EYEN) Delisted | Chief Financial Officer | 100 | $15.82 | $1.6K | $30.9K | 11 | 2024-02-14 |
| Xtant Medical Holdings, Inc. (BONE) Delisted | CFO and Interim Co-CEO | 994 | — | — | $35.0K | 3 | 2013-05-29 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-15 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2025-09-04 | ECOR | Grant (A) | +19,011 | $0 | EDGAR |
| 2025-05-27 | ECOR | Buy (P) | +1,800 | $9.0K | EDGAR |
| 2024-09-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2024-09-05 | ECOR | Grant (A) | +16,583 | $0 | EDGAR |
| 2024-06-17 | ECOR | Buy (P) | +1,000 | $6.4K | EDGAR |
| 2024-02-14 | HYPERION DEFI, INC. (EYEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-16 | — | Mixed | +1,500,000 | $135.0K | |
| 2023-10-06 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-08-08 | ECOR | Grant (A) | +21,739 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.